Skip to main content
. 2021 Dec 24;8:793102. doi: 10.3389/fmed.2021.793102

Figure 1.

Figure 1

SARS-CoV-2-specific T cell responses to various proteins at different stages of exposure (A) in infection and vaccination can be quantified by (B) activation induced markers, pMHC tetramer or multimer binding for known immunodominant epitopes, or by cytokine induction (B). Figure produced with Biorender.